miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion

Conclusions: CD133+ CD34− is a CSC marker in H1650. miR-27a is highly expressed in H1650 CSCs and regulates cancer development in H1650. miR-27a may be a potential target for NSCLC therapy.

Source: Journal of Cancer Research and Therapeutics - December 11, 2018 Category: Cancer & Oncology Authors: Wenwen Luo Deyi Zhang Shumin Ma Chenyao Wang Qian Zhang Huafei Wang Kunyan He Zhixue Liu Source Type: research